Ropes Wealth Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ropes Wealth Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-5	Closed	-$1K	–	513
2020 Q4	$1K	Buy	+5	New	+$745	﹤0.01%	725

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Ropes Wealth Advisors's JAZZ Position: Q1 2021 in Review

Ropes Wealth Advisors sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2021, closing a stake of 5 shares — an estimated $1K sold.

Ropes Wealth Advisors first reported a position in JAZZ in Q4 2020 and held it in 1 quarter. The position peaked at $1K in Q4 2020. 442 funds tracked by Wall St. Rank hold JAZZ as of Q1 2021.

Ropes Wealth Advisors reported no remaining Jazz Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
Ropes Wealth Advisors sold 5 Jazz Pharmaceuticals shares in Q1 2021, an estimated $1K.
Ropes Wealth Advisors first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 1 quarter.
Ropes Wealth Advisors's Jazz Pharmaceuticals position peaked at $1K in Q4 2020.
442 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2021.

Based on Ropes Wealth Advisors's 13F filing for Q1 2021, filed 12 May 2021.